# Task A26: In Vitro Screening for Antifungal Activity Against Fungal Disease Pathogens

> **NIH NIH N01** · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · 2024 · $69,565

## Abstract

This contract provides in vitro testing of potential anti-fungal agents, efficacy to combat the effects of toxins produced by fungi, maintenance of fungal and toxin stocks, and the development of related assays.

## Key facts

- **NIH application ID:** 11080837
- **Project number:** 75N93019D00022-0-759302400001-2
- **Recipient organization:** UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- **Principal Investigator:** THOMAS PATTERSON
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $69,565
- **Award type:** —
- **Project period:** 2024-01-15 → 2025-01-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11080837

## Citation

> US National Institutes of Health, RePORTER application 11080837, Task A26: In Vitro Screening for Antifungal Activity Against Fungal Disease Pathogens (75N93019D00022-0-759302400001-2). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/11080837. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*